Sleep Disorders Trial, Recruiting NCT05336890 Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05336890
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were previously enrolled in the Pre-Vent Study under an approved research protocol, either by signing a consent form or under a protocol that allowed being contacted again for future research
  • People who were born before 29 weeks of pregnancy (very premature birth)
  • People who are under 7 years old at the time of joining this study

Who may not be able to join:

  • People who were withdrawn from the Pre-Vent study for any reason after the consent form was signed
  • People for whom no health or body measurement data was recorded as part of the Pre-Vent study
  • People whose local ethics board or child and family services authority has not given approval for researchers to make contact again (confirm with trial site)
  • People who have been adopted by a family who has not given consent to be contacted
  • People whose parent or guardian previously said they did not want to be contacted again before this follow-up study began
  • People who were originally enrolled in the Pre-Vent study at Washington University in St. Louis, as that location is not part of this follow-up study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Debra Weese-Mayer, MD, Ann & Robert H Lurie Children's Hospital of Chicago

Phone: 312-227-3300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Registry
ClinicalTrials.gov
Start date
1 November 2022
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Asthma; Sleep Disordered Breathing (SDB); Neurodevelopmental Impairment (NDI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov